Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
This prospective multicenter, double blind study will evaluate the efficacy and safety of aliskiren versus ramipril in patients with moderate systolic essential hypertension.
Inclusion Criteria:
Outpatients > 18 years
Male or female patients. Female patients must have been either post-menopausal for one year, surgically sterile, or using effective contraceptive methods
Patients with essential hypertension, previously treated with an antihypertensive single-drug therapy, either uncontrolled or intolerant.
BP thresholds at visit 1:
BP thresholds at visit 2 (for all patients):
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
Aire Sur Adour, France
Chatillon Sur Colmon, France
Les Maguelone, France
Vereneque, France